Skip to main content
. 2020 Jun 23;20:443. doi: 10.1186/s12879-020-05124-1

Table 1.

Prevalence and determinants of virological failure on ART among PLWH

Variables VL ≥ 1000 copies/ml Total N ORu ORm
Virologic failure
n = 2156 (rate, n/N%)
Socio-demographics
Gender
  Female 710 (36.90) 1925 1.0(ref) 1.0(ref)
  Male 1446 (44.70) 3232 1.39 (1.23–1.56)*** 1.25 (1.03–1.50)***
Age
  ≤ 15 172 (48.86) 352 1.0 (Ref.)
  15 ~ 40 1423 (41.45) 3433 0.74 (0.59–0.92) ***
  >40 533 (40.94) 1302 0.72 (0.57–0.92) ***
  Unknown 28 (40.00) 70
Occupation
  Employed 37 (34.91) 106 1.0 (Ref.)
  Peasant 1736 (41.85) 4148 1.34 (0.90–2.01)
  Students and children 136 (46.74) 291 1.64 (1.03–2.60)**
  Unknown 247 (40.36) 612
Current marital status
  Married 1406 (41.80) 3366 1.0 (Ref.)
  Single 428 (45.77) 934 1.18 (1.02–1.36) **
  Widowed or Divorced 99 (35.87) 276 0.78 (0.60–1.01)*
  Unknown 223 (38.38) 581
Ethnicity (0.00)
  Yi 2137 (41.70) 5125 1.0 (Ref.)
  Han and others 19 (59.38) 32 2.04 (1.01–4.15)**
Education level
  Illiteracy 1339 (42.58) 3145 1.0 (Ref.) 1.0 (Ref.)
  Primary school 581 (40.77) 1425 0.93 (0.82–1.05)* 0.77 (0.66–0.89)**
  Secondary or above 70 (38.67) 181 0.85 (0.63–1.16) 0.69 (0.46–1.04)
  Unknown 166 (40.89) 406
HIV transmission route
  Heterosexual behaviors 715 (37.10) 1927 1.0 (Ref.) 1.0 (Ref.)
  Drug injection 747 (43.08) 1734 1.28 (1.12–1.47)*** 1.12 (0.93–1.35)
  Heterosexual behaviors and drug injection 325 (49.02) 663 1.63 (1.36–1.95) *** 1.44 (1.15–1.82)**
  Mother to child 163 (48.95) 333 1.63 (1.29–2.05) *** 1.58 (1.21–2.08)**
  Others and unknown 206 (41.20) 500
The first CD4+counts, counts/ul
  ≤ 200 346 (46.82) 739 1.0 (Ref.)
  200 ~ 500 986 (41.29) 2388 0.80 (0.68–0.94)**
  >500 646 (40.68) 1588 0.78 (0.65–0.93)**
  Unknown 178 (40.27) 442
Stage of disease
  HIV 784 (37.44) 2094 1.0 (Ref.) 1.0 (Ref.)
  AIDS 985 (44.49) 2214 1.34 (1.19–1.51) *** 1.35 (1.17–1.55)***
  Unknown 387 (45.58) 849
HIV-related behaviors
Needle sharing
  Had never used illicit drugs and shared the needle 1001 (39.03) 2565 1.0 (Ref.) 1.0 (Ref.)
  Had shared needle for 1 ~ 4 times 519 (43.43) 1195 1.20 (1.04–1.38)** 1.34 (1.09–1.65)**
  Had shared needle ≥5 times 421 (48.00) 877 1.44 (1.24–1.68) *** 1.52 (1.21–1.91)***
  Unknown 215 (41.35) 520
Number of casual sexual partners
  0 1089 (42.51) 2562 1.0 (Ref.)
  1 ~ 4 508 (38.99) 1303 0.86 (0.75–0.99)**
  ≥ 5 344 (44.56) 772 1.09 (0.92–1.28)
  Unknown 215 (41.35) 520
History of sexually transmitted diseases except for HIV
  Never 1494 (42.53) 3513 1.0 (Ref.)
  Ever 100 (38.46) 260 0.85 (0.65–1.09)
ART related information
Time of ART
  < 12 304 (43.55) 698 1.0 (Ref.) 1.0 (Ref.)
  12 ~ 36 682 (40.38) 1689 0.88 (0.73–1.05)* 0.72 (0.60–0.92)**
  > 36 728 (40.00) 1820 0.86 (0.72–1.03)* 0.66 (0.53–0.83)***
  Unknown 442 (46.53) 950
Initial regimen of ART
  TDF + 3TC + EFV/NVP 1202 (39.97) 3007 1.0 (Ref.)
  AZT + 3TC + EFV/NVP 444 (44.36) 1001 1.20 (1.04–1.38)**
  LPV/r + 3TC + AZT/TDF 48 (33.33) 144 0.75 (0.53–1.07)*
  Unknown 462 (45.97) 1005 =
Replacement of ART regimen
  Never 1535 (40.16) 3822 1.0 (Ref.) 1.0 (Ref.)
  Ever 181 (46.65) 388 1.30 (1.06–1.61)** 1.48 (1.12–1.96)**

ORu univariate odds ratios, ORm multivariate odds ratios, CI confidence interval, TDF tenofovir, 3TC lamivudine, NVP nevirapine, EFV efavirenz, AZT Zidovudine, LPV/r fosamprenavir/ritonavir

Variables with p < 0.2 in the univariate analysis as candidates were selected by a summary multiple logistic regression model

*P value< 0.2; **P value< 0.05; ***P value< 0.001